Anebulo Pharmaceuticals Inc. (ANEB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Anebulo Pharmaceuticals I...

    NASDAQ: ANEB · Real-Time Price · USD
    2.31
    -0.09 (-3.75%)
    At close: Oct 03, 2025, 3:59 PM
    2.31
    0.00%
    After-hours: Oct 03, 2025, 04:52 PM EDT

    Anebulo Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a
    Operating Income
    		 -9.22M -8.31M -11.78M -6.83M -3.61M
    Interest Income
    		 -257.91K 249.02K 92.41K 7.33K 1.02K
    Pretax Income
    		 -8.48M -8.2M -11.73M -6.83M -30.25M
    Net Income
    		 -8.48M -8.2M -11.73M -6.83M -30.25M
    Selling & General & Admin
    		 4.92M 4.76M 6.18M 3.87M 1.34M
    Research & Development
    		 4.3M 3.55M 5.6M 2.96M 2.27M
    Other Expenses
    		 n/a n/a -41.15K -1.78K -1.34K
    Operating Expenses
    		 9.22M 8.31M 11.78M 6.83M 3.61M
    Interest Expense
    		 382.01K 151.23K n/a 7.33K 11.77K
    Selling & Marketing Expenses
    		 n/a 4.8K n/a n/a n/a
    Cost & Expenses
    		 n/a 8.31M 11.78M 6.83M 3.61M
    Income Tax Expense
    		 n/a n/a -104K -12.89K 10.75K
    Shares Outstanding (Basic)
    		 33.82M 25.82M 25.07M 23.34M 23.34M
    Shares Outstanding (Diluted)
    		 33.82M 25.82M 25.07M 23.34M 23.34M
    EPS (Basic)
    		 -0.25 -0.32 -0.47 -0.29 -1.3
    EPS (Diluted)
    		 -0.25 -0.32 -0.47 -0.29 -1.3
    EBITDA
    		 -9.22M -8.05M -11.78M 5.55K -30.24M
    EBIT
    		 n/a -8.05M -11.73M -6.83M -30.24M
    Depreciation & Amortization
    		 n/a 258.28K 11.78M 6.83M n/a

    Add to Watchlist